@article {Notghie535, author = {Alp AA Notghi and Joseph Atley and Mark Silva}, title = {Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination}, volume = {21}, number = {5}, pages = {e535--e538}, year = {2021}, doi = {10.7861/clinmed.2021-0470}, publisher = {Royal College of Physicians}, abstract = {Longitudinal extensive transverse myelitis (LETM) is a rare but recognised complication of vaccination. We report the case of a 58-year-old man admitted to hospital 10 days after his first AstraZeneca COVID-19 vaccination with progressive neurological symptoms and signs, and investigations and imaging consistent with LETM.This case reviews the literature and the investigative process behind excluding other diagnoses given the patient{\textquoteright}s background of pulmonary sarcoidosis. It is unique in being the first UK report of a case of LETM with a strong temporal link to COVID-19 vaccination.}, issn = {1470-2118}, URL = {https://www.rcpjournals.org/content/21/5/e535}, eprint = {https://www.rcpjournals.org/content/21/5/e535.full.pdf}, journal = {Clinical Medicine} }